Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia
✍ Scribed by R. El Kares; M. R. Barbouche; H. Elloumi-Zghal; M. Bejaoui; J. Chemli; F. Mellouli; N. Tebib; M. S. Abdelmoula; S. Boukthir; Z. Fitouri; S. M’Rad; K. Bouslama; H. Touiri; S. Abdelhak; M. K. Dellagi
- Publisher
- Nature Publishing Group
- Year
- 2006
- Tongue
- English
- Weight
- 279 KB
- Volume
- 51
- Category
- Article
- ISSN
- 1435-232X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The routine testing for pathologic mutation(s) in a patient's DNA has become the foundation of modern molecular genetic diagnosis. It is especially valuable when the phenotype shows genetic heterogeneity, and its importance will grow as treatments become genotype specific. However, the technology of
Defects in the phagocyte NADPH oxidase give rise to chronic granulomatous disease (CGD) (Roos, 1994). Two components, gp91-phox and p22-phox, comprise the membrane-associated cytochrome bSss. Defects in the former account for the most common, X-linked form of CGD, for which a large number of mutatio
Three dominantly inherited "pure" form of familial spastic paraplegia (FSP) genes have been genetically mapped to regions of chromosomes, yet no specific genes or mutations have been identified (FSPI ; chromosome 14q, FSP2; chromosome 2p and FSP3; chromosome 15q). We studied a "pure" form of autosom